Evaxion A/S

Evaxion A/S

Biotechnology-Research

Hørsholm, Capital Re...
Denmark
Company Tagline

evaxion.ai

Industry Category
Biotechnology-Research
Company Description

Evaxion A/S is a leading TechBio company dedicated to transforming patient lives through innovative and targeted treatment options. Based in Hørsholm, Capital Region, Denmark, Evaxion operates from its primary address at Dr. Neergaards Vej 5F, Hørsholm, Capital Region 2970, DK.

At the heart of Evaxion A/S is its proprietary AI platform, AI-Immunology™. This cutting-edge, scalable AI prediction model harnesses the power of artificial intelligence to decode the human immune system. Evaxion leverages this technology to develop novel immunotherapies aimed at combating cancer, bacterial diseases, and viral infections. The company is focused on providing innovative healthcare solutions.

Evaxion has developed a robust clinical-stage oncology pipeline of personalized vaccines and a preclinical infectious disease pipeline targeting bacterial and viral diseases with high unmet medical needs. Evaxion A/S is committed to pushing the boundaries of biotechnology research and development, striving to create impactful advancements in the field. We invite the manager of Evaxion A/S to create a customized and exclusive company showcase and product listing on our platform.

Evaxion A/S er en førende TechBio-virksomhed, der er dedikeret til at transformere patienters liv gennem innovative og målrettede behandlingsmuligheder. Med base i Hørsholm, Region Hovedstaden, Danmark, opererer Evaxion fra sin primære adresse på Dr. Neergaards Vej 5F, Hørsholm, Region Hovedstaden 2970, DK.

Kernen i Evaxion A/S er dens proprietære AI-platform, AI-Immunology™. Denne banebrydende, skalerbare AI-forudsigelsesmodel udnytter kraften i kunstig intelligens til at afkode det menneskelige immunsystem. Evaxion udnytter denne teknologi til at udvikle nye immunoterapier, der er rettet mod bekæmpelse af kræft, bakterielle sygdomme og virusinfektioner. Virksomheden er fokuseret på at levere innovative sundhedsløsninger.

Evaxion har udviklet en robust klinisk-stadie onkologi-pipeline af personlige vacciner og en præklinisk infektiøs sygdoms-pipeline, der er rettet mod bakterielle og virussygdomme med høje udækkede medicinske behov. Evaxion A/S er engageret i at flytte grænserne for bioteknologisk forskning og udvikling og stræber efter at skabe virkningsfulde fremskridt inden for området. Vi inviterer lederen af Evaxion A/S til at oprette en skræddersyet og eksklusiv virksomhedsfremvisning og produktliste på vores platform.

Key Personnel / Employees
Lars Staal Wegner MD Thomas Strandet Jepsen Birgitte Rønø Niels Iversen Moller

Compare Companies Side by Side

Compare Evaxion A/S with 3 companies in Biotechnology-Research

4 Companies
Comparison Field
Evaxion A/S
Evaxion A/S
Main Company
AliveX Biotech
AliveX Biotech
View Profile
Molecular Intellect
Molecular Intellect
View Profile
Founded Year
2014 2019 2025
Company Size
51-200 51-200 2-10
City
Hørsholm, Capital Region Redwood City, CA Sydney, NSW Raleigh-Durham, NC
Country
Denmark United States Australia
Skills & Keywords Comparing with main company
14 Total Skills
Biotechnology Immunotherapy AI-Immunology Vaccines Oncology Infectious Diseases Artificial Intelligence Bioinformatics AI Immunoinformatics Antigen Discovery Neo Epitope Discovery Immuno-Oncology Biotech
13 Total 13 Unique
Unique Skills:
Cell-free DNA Clinical care Computational Biology Data Science Diagnostics Genomics +7
8 Total 8 Unique
Unique Skills:
Computational Biology Diagnostics Genomics Immunology MIDD Multi-omics +2
18 Total 1 Common 17 Unique
Match 7%
Common Skills:
Biotechnology
Unique Skills:
AlphaFold Biology Computational Biochemistry Computational Biology Computational Chemistry Digital Health +11
4
Total Companies
2014
Oldest Founded
3
Countries
48
Unique Skills

Similar Companies

Other organizations in the same industry

IGA Technology Services
Biotechnology-Research

Applying genomics: food origin & safety, plant & animal breeding, diagnostics & clinical care

Udine, UD
Italy
m-lab GmbH
Biotechnology-Research

We strive to develop Lateral Flow Assays for point-of-care diagnosis and antibody-based treatments

Mainz, Rhineland-Pal...
Germany
AccuStem
Biotechnology-Research

Our mission at AccuStem is to optimize outcomes for all patients with cancer across the globe.

Optima Nanomed Limited
Biotechnology-Research

No drug left behind. No disease left uncured.

Alternative Company Names

This company is also known as

Evaxion A/S इवैकसियन ए/एस إيفاكسيون إيه/إس Эваксион А/С